Advanced in Autoimmune Hemolytic Anemia

Dr. Luis J. Cuervo

Oncology | Hematology
Spencer Municipal Hospital
1200 1 Ave E, 
Spencer, IA 
 (711.9 mi)
Accepting New Patients
Offers Telehealth
Advanced in Autoimmune Hemolytic Anemia
Spencer Municipal Hospital
1200 1 Ave E, 
Spencer, IA 
 (711.9 mi)
OverviewInsuranceLocationsClinical Research

Overview

Luis Cuervo is an Oncologist and a Hematologist in Spencer, Iowa. Dr. Cuervo and is rated as an Advanced provider by MediFind in the treatment of Autoimmune Hemolytic Anemia. His top areas of expertise are Thrombocytopenia, Familial Colorectal Cancer, Colorectal Cancer, and Anemia. Dr. Cuervo is currently accepting new patients.

His clinical research consists of participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.

Graduate Institution
University Of Texas Medical Branch At Galveston
Specialties
Oncology
Hematology
Licenses
Internal Medicine in TX
Hospital Affiliations
Avera Holy Family Hospital
Pocahontas Community Hospital
Palo Alto County Hospital
Lakes Regional Healthcare
Spencer Municipal Hospital
Languages Spoken
English
Spanish
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Sanford Health
  •  Wellmark

Locations

SPENCER MUNICIPAL HOSPITAL
1200 1 Ave E, Spencer, IA 51301

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

eMonarcHER: A Randomized, Double Blind, Placebo-Controlled Phase 3 Study of Abemaciclib Plus Standard Adjuvant Endocrine Therapy in Participants With High-Risk, Node-Positive, HR+, HER2+ Early Breast Cancer Who Have Completed Adjuvant HER2-Targeted Therapy
eMonarcHER: A Randomized, Double Blind, Placebo-Controlled Phase 3 Study of Abemaciclib Plus Standard Adjuvant Endocrine Therapy in Participants With High-Risk, Node-Positive, HR+, HER2+ Early Breast Cancer Who Have Completed Adjuvant HER2-Targeted Therapy
Enrollment Status: Terminated
Publish Date: July 25, 2024
Intervention Type: Drug
Study Drugs: Abemaciclib, Standard Adjuvant Endocrine Therapy
Study Phase: Phase 3
Similar Doctors
Experienced in Autoimmune Hemolytic Anemia
Dr. Stephan D. Thome
Hematology Oncology | Oncology | Hematology
Experienced in Autoimmune Hemolytic Anemia
Dr. Stephan D. Thome
Hematology Oncology | Oncology | Hematology

Mayo Clinic Health System-Fairmont

800 Medical Ctr Dr, 
Fairmont, MN 
 (50.3 mi)
507-238-8555
Languages Spoken:
English, German
See accepted insurances
Accepting New Patients
Offers Telehealth

Stephan Thome is a Hematologist Oncology specialist and an Oncologist in Fairmont, Minnesota. Dr. Thome and is rated as a Distinguished provider by MediFind in the treatment of Autoimmune Hemolytic Anemia. His top areas of expertise are Paget Disease of the Breast, Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), and Familial Colorectal Cancer. Dr. Thome is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile